Skip to main content
Published Online:https://doi.org/10.3928/01477447-20191001-01Cited by:3

Abstract

Limb salvage is the treatment of choice for malignant shoulder girdle tumors; however, there is a paucity of data examining the long-term outcome. The authors have previously reported on a cohort of patients at short- and mid-term follow-up. The purpose of this study was to report the long-term outcome of shoulder reconstruction in terms of oncological and functional outcome. The authors reviewed 53 patients who underwent a limb salvage procedure for treatment of a tumor of the shoulder girdle. At a mean of 28 years following the resection, 76% of surviving patients were contacted and administered functional outcome scores using the Musculoskeletal Tumor Society (MSTS) and Toronto Extremity Salvage (TESS). The 20-year survival and recurrence-free survival were 79% and 80%, respectively. Likewise, the 20-year revision survival was 75%, with a limb salvage rate of 94%. At last follow-up, the mean MSTS rating and TESS score were 75% and 85%, respectively, with 9 patients having improvement in their MSTS rating from the previous findings. Limb salvage following resection of shoulder girdle tumor resulted in acceptable means of oncological outcome and function. Some patients continued to experience improvements in functional outcome even at late (>20 years) follow-up. [Orthopedics. 2019; 42(6):e514–e520.]

  • 1.O'Connor MI, Sim FH, Chao EY. Limb salvage for neoplasms of the shoulder girdle: intermediate reconstructive and functional results. J Bone Joint Surg Am. 1996; 78(12):1872–1888.10.2106/00004623-199612000-000118986665

    Crossref MedlineGoogle Scholar
  • 2.Enneking W, Dunham W, Gebhardt M, Malawar M, Pritchard D. A system for the classification of skeletal resections. Chir Organi Mov. 1990; 75(suppl 1):217–240.2249538

    MedlineGoogle Scholar
  • 3.Enneking WF. A system of staging musculoskeletal neoplasms. Clin Orthop Relat Res. 1986;(204):9–24.3456859

    MedlineGoogle Scholar
  • 4.McGrory BJ, Morrey BF, Rand JA, Ilstrup DM. Correlation of patient questionnaire responses and physician history in grading clinical outcome following hip and knee arthroplasty: a prospective study of 201 joint arthroplasties. J Arthroplasty. 1996; 11(1):47–57.10.1016/S0883-5403(96)80160-48676118

    Crossref MedlineGoogle Scholar
  • 5.Enneking WF, Dunham W, Gebhardt MC, Malawar M, Pritchard DJ. A system for the functional evaluation of reconstructive procedures after surgical treatment of tumors of the musculoskeletal system. Clin Orthop Relat Res. 1993;(286):241–246.8425352

    MedlineGoogle Scholar
  • 6.Davis AM, Wright JG, Williams JI, Bombardier C, Griffin A, Bell RS. Development of a measure of physical function for patients with bone and soft tissue sarcoma. Qual Life Res. 1996; 5(5):508–516.10.1007/BF005400248973131

    Crossref MedlineGoogle Scholar
  • 7.Abdeen A, Hoang BH, Athanasian EA, Morris CD, Boland PJ, Healey JH. Allograft-prosthesis composite reconstruction of the proximal part of the humerus: functional outcome and survivorship. J Bone Joint Surg Am. 2009; 91(10):2406–2415.10.2106/JBJS.H.0081519797576

    Crossref MedlineGoogle Scholar
  • 8.Kumar D, Grimer RJ, Abudu A, Carter SR, Tillman RM. Endoprosthetic replacement of the proximal humerus: long-term results. J Bone Joint Surg Br. 2003; 85(5):717–722.10.1302/0301-620X.85B5.1383812892196

    Crossref MedlineGoogle Scholar
  • 9.Frassica FJ, Sim FH, Chao EY. Primary malignant bone tumors of the shoulder girdle: surgical technique of resection and reconstruction. Am Surg. 1987; 53(5):264–269.3472479

    MedlineGoogle Scholar
  • 10.Gebhardt MC, Roth YF, Mankin HJ. Osteoarticular allografts for reconstruction in the proximal part of the humerus after excision of a musculoskeletal tumor. J Bone Joint Surg Am. 1990; 72(3):334–345.10.2106/00004623-199072030-000042135632

    Crossref MedlineGoogle Scholar
  • 11.Getty PJ, Peabody TD. Complications and functional outcomes of reconstruction with an osteoarticular allograft after intraarticular resection of the proximal aspect of the humerus. J Bone Joint Surg Am. 1999; 81(8):1138–1146.10.2106/00004623-199908000-0000910466646

    Crossref MedlineGoogle Scholar
  • 12.Probyn LJ, Wunder JS, Bell RS, Griffin AM, Davis AM. A comparison of outcome of osteoarticular allograft reconstruction and shoulder arthrodesis following resection of primary tumours of the proximal humerus. Sarcoma. 1998; 2(3–4):163–170.10.1080/13577149877920

    Crossref MedlineGoogle Scholar
  • 13.Grosel TW, Plummer DR, Mayerson JL, Scharschmidt TJ, Barlow JD. Oncologic reconstruction of the proximal humerus with a reverse total shoulder arthroplasty megaprosthesis. J Surg Oncol. 2018; 118(6):867–872.10.1002/jso.2506130151889

    Crossref MedlineGoogle Scholar
  • 14.Sanchez-Sotelo J, Wagner ER, Sim FH, Houdek MT. Allograft-prosthetic composite reconstruction for massive proximal humeral bone loss in reverse shoulder arthroplasty. J Bone Joint Surg Am. 2017; 99(24):2069–2076.10.2106/JBJS.16.0149529257012

    Crossref MedlineGoogle Scholar
  • 15.Maclean S, Malik SS, Evans S, Gregory J, Jeys L. Reverse shoulder endoprosthesis for pathologic lesions of the proximal humerus: a minimum 3-year follow-up. J Shoulder Elbow Surg. 2017; 26(11):1990–1994.10.1016/j.jse.2017.04.00528684229

    Crossref MedlineGoogle Scholar
  • 16.Elhassan BT, Wagner ER, Werthel JD, Lehanneur M, Lee J. Outcome of reverse shoulder arthroplasty with pedicled pectoralis transfer in patients with deltoid paralysis. J Shoulder Elbow Surg. 2018; 27(1):96–103.10.1016/j.jse.2017.07.007

    Crossref MedlineGoogle Scholar
  • 17.Bos G, Sim F, Pritchard D, et al.Prosthetic replacement of the proximal humerus. Clin Orthop Relat Res. 1987;(224):178–191.3665239

    MedlineGoogle Scholar
  • 18.Mayilvahanan N, Paraskumar M, Sivaseelam A, Natarajan S. Custom mega-prosthetic replacement for proximal humeral tumours. Int Orthop. 2006; 30(3):158–162.10.1007/s00264-005-0029-z16565840

    Crossref MedlineGoogle Scholar
  • 19.Cannon CP, Paraliticci GU, Lin PP, Lewis VO, Yasko AW. Functional outcome following endoprosthetic reconstruction of the proximal humerus. J Shoulder Elbow Surg. 2009; 18(5):705–710.10.1016/j.jse.2008.10.01119186077

    Crossref MedlineGoogle Scholar
  • 20.Tang X, Guo W, Yang R, Tang S, Ji T. Synthetic mesh improves shoulder function after intraarticular resection and prosthetic replacement of proximal humerus. Clin Orthop Relat Res. 2015; 473(4):1464–1471.10.1007/s11999-015-4139-725604875

    Crossref MedlineGoogle Scholar
  • 21.Rosenberg SA, Tepper J, Glatstein E, et al.The treatment of soft-tissue sarcomas of the extremities: prospective randomized evaluations of (1) limb-sparing surgery plus radiation therapy compared with amputation and (2) the role of adjuvant chemotherapy. Ann Surg. 1982; 196(3):305–315.10.1097/00000658-198209000-000097114936

    Crossref MedlineGoogle Scholar
  • 22.Wright EH, Gwilym S, Gibbons CL, Critchley P, Giele HP. Functional and oncological outcomes after limb-salvage surgery for primary sarcomas of the upper limb. J Plast Reconstr Aesthet Surg. 2008; 61(4):382–387.10.1016/j.bjps.2007.01.080

    Crossref MedlineGoogle Scholar
  • 23.Reddy KI, Wafa H, Gaston CL, et al.Does amputation offer any survival benefit over limb salvage in osteosarcoma patients with poor chemonecrosis and close margins?Bone Joint J. 2015; 97-B(1):115–120.10.1302/0301-620X.97B1.3392425568424

    Crossref MedlineGoogle Scholar
  • 24.Wu J, Sun H, Li J, et al.Increased survival of patients aged 0–29 years with osteosarcoma: a period analysis, 1984–2013. Cancer Med. 2018; 7(8):3652–3661.10.1002/cam4.165929992762

    Crossref MedlineGoogle Scholar
  • 25.Bacci G, Briccoli A, Ferrari S, et al.Neoadjuvant chemotherapy for osteosarcoma of the extremity: long-term results of the Rizzoli's 4th protocol. Eur J Cancer. 2001; 37(16):2030–2039.10.1016/S0959-8049(01)00229-511597381

    Crossref MedlineGoogle Scholar
  • 26.Tsuda Y, Ogura K, Shinoda Y, Kobayashi H, Tanaka S, Kawai A. The outcomes and prognostic factors in patients with osteosarcoma according to age: a Japanese nationwide study with focusing on the age differences. BMC Cancer. 2018; 18(1):614.10.1186/s12885-018-4487-229855362

    Crossref MedlineGoogle Scholar
  • 27.Akiyama T, Uehara K, Ogura K, et al.Cross-cultural adaptation and validation of the Japanese version of the Toronto Extremity Salvage Score (TESS) for patients with malignant musculoskeletal tumors in the upper extremities. J Orthop Sci. 2017; 22(1):127–132.10.1016/j.jos.2016.09.012

    Crossref MedlineGoogle Scholar
  • 28.Uehara K, Ogura K, Akiyama T, et al.Reliability and validity of the Musculoskeletal Tumor Society scoring system for the upper extremity in Japanese patients. Clin Orthop Relat Res. 2017; 475(9):2253–2259.10.1007/s11999-017-5390-x28560530

    Crossref MedlineGoogle Scholar
  • 29.Angst F, Schwyzer HK, Aeschlimann A, Simmen BR, Goldhahn J. Measures of adult shoulder function: Disabilities of the Arm, Shoulder, and Hand Questionnaire (DASH) and its short version (QuickDASH), Shoulder Pain and Disability Index (SPADI), American Shoulder and Elbow Surgeons (ASES) Society standardized shoulder assessment form, Constant (Murley) Score (CS), Simple Shoulder Test (SST), Oxford Shoulder Score (OSS), Shoulder Disability Questionnaire (SDQ), and Western Ontario Shoulder Instability Index (WOSI). Arthritis Care Res (Hoboken). 2011; 63(suppl 11):S174–S188.10.1002/acr.20630

    Crossref MedlineGoogle Scholar

We use cookies on this site to enhance your user experience. For a complete overview of all the cookies used, please see our privacy policy.

×